Clinical trials: Exogenous Obesity
Obesity
Incretin Effect in People With Impaired Fasting Glucose
Regulation of endogenous glucose production (EGP) and insulin secretion are major actions of glucagon-like peptide-1 (GLP-1). Determining whether alterations in GLP-1 may contribute to abnormal EGP and insulin secretion in people…
- Trial name
- 1651 (NCT00795275)
- Testing
- Sitagliptin Phosphate
- Where
- United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Alimentary Obesity
The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity
The aim of this study is to summarize the data on efficacy and safety of Reduxine administration in the routine clinical practice according to the approved indications.
- Trial name
- Primavera (NCT01773733)
- Volunteers
- 98,774 people
- Sponsor
- Promomed, LLC
Weight Loss, Obesity
Testing the Effectiveness of WW Clinic GLP1
The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes.
- Trial name
- WW Clinic (NCT06034457)
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- The Cleveland Clinic